Scalper1 News
Following a three-day plummet, stocks popped Tuesday, with several top drugmakers like Gilead making a climb. Today’s Screen of the Day focuses on Top Sector Performers. Over half of a stock’s price move can be attributed to the strength of its industry subgroup and sector. Biotech Gilead Sciences (GILD) develops treatments for HIV/AIDS, liver diseases, heart disease and other life-threatening illnesses. Gilead’s blockbuster hepatitis C Scalper1 News
Scalper1 News